semaglutide altamonte springs Alonso MedSpa and Wellness Center (@alonsomedspa) · Altamonte Springs, FL Personalized Compounded Semaglutide in Silver

Kidney outcomes in cardiovascular trials: Analyses from SUSTAIN-6, LEADER, and other trials consistently show reductions in kidney-related outcomes with GLP-1 treatment

For several years now, we have seen from randomized controlled trials that SGLT2 inhibitors and GLP-1 receptor agonists have the ability to reduce the risk of cardiovascular disease, which includes stroke, heart attack and death, said Cheryl Bushnell, MD, a professor in the department of neurology at Wake Forest University

If approved, they will prescribe your treatment and build a safe dosage plan, often starting low and tapering up gradually only as tolerated

*Compounded semaglutide and tirzepatide are not FDA-approved, are not generic versions of FDA-approved drugs like Ozempic, Wegovy, Mounjaro, or Zepbound, and are not reviewed by FDA for safety, effectiveness, or quality